These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7403329)

  • 1. Biological effects of 15-hydroperoxythromboxane A2 on platelets and aorta.
    Hammarström S
    Prostaglandins Med; 1980 May; 4(5):297-302. PubMed ID: 7403329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR
    Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of prostaglandins and thromboxane A2 on the contractility of rabbit splenic capsular smooth muscle.
    Peskar BA; Förstermann U; Simmet T
    Artery; 1980; 8(1):1-6. PubMed ID: 7000038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis and biological properties of prostaglandin endoperoxides and thromboxane A2.
    Svensson J
    Acta Biol Med Ger; 1978; 37(5-6):731-40. PubMed ID: 742285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of trapidil on thromboxane A2-induced aggregation of platelets, ischemic changes in heart and biosynthesis of thromboxane A2.
    Ohnishi H; Kosuzume H; Hayashi Y; Yamaguchi K; Suzuki Y; Itoh R
    Prostaglandins Med; 1981 Mar; 6(3):269-81. PubMed ID: 6894333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.
    Lefer AM; Smith EF; Araki H; Smith JB; Aharony D; Claremon DA; Magolda RL; Nicolaou KC
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1706-10. PubMed ID: 6929517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human platelet thromboxane synthetase by 11a-carbathromboxane A2 analogs.
    Gorman RR; Maxey KM; Bundy GL
    Biochem Biophys Res Commun; 1981 May; 100(1):184-90. PubMed ID: 7196228
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioassay of thromboxane A2 by contraction of guinea-pig lung parenchymal strip.
    Spławiński J; Wojtaszek B; Marcinkiewicz E
    Thromb Res; 1981 Jan 1-15; 21(1-2):35-44. PubMed ID: 6112804
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veins.
    Mais DE; Dunlap C; Hamanaka N; Halushka PV
    Eur J Pharmacol; 1985 Apr; 111(1):125-8. PubMed ID: 4018122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane A2: effects on airway and vascular smooth muscle.
    Svenssen J; Strandberg K; Tuvemo T; Hamberg M
    Prostaglandins; 1977 Sep; 14(3):425-36. PubMed ID: 905570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independence of the cyclic AMP-lowering activity of thromboxane A2 from the platelet release reaction.
    Gorman RR; Wierenga W; Miller OV
    Biochim Biophys Acta; 1979 Jan; 572(1):95-104. PubMed ID: 216409
    [No Abstract]   [Full Text] [Related]  

  • 12. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 13. Impaired platelet response to thromboxane-A2 and defective calcium mobilization in a patient with a bleeding disorder.
    Lages B; Malmsten C; Weiss HJ; Samuelsson B
    Blood; 1981 Mar; 57(3):545-52. PubMed ID: 7459434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle.
    Samuelsson B
    Acta Biol Med Ger; 1976; 35(8-9):1055-63. PubMed ID: 1007751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pinane thromboxane A2: a TXA2 antagonist with antithrombotic properties.
    Aharony D; Smith JB; Smith EF; Lefer AM; Magolda RL; Nicolaou KD
    Adv Prostaglandin Thromboxane Res; 1980; 6():489-92. PubMed ID: 6992538
    [No Abstract]   [Full Text] [Related]  

  • 16. A 16-p-fluorophenoxy prostanoid with potent and long-lasting thromboxane-like actions [proceedings].
    Jones RL; Wilson NH
    Br J Pharmacol; 1978 Jun; 63(2):362P. PubMed ID: 667444
    [No Abstract]   [Full Text] [Related]  

  • 17. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
    Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations.
    Jones RL; Wilson NH
    Adv Prostaglandin Thromboxane Res; 1980; 6():467-75. PubMed ID: 7386280
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro and in vivo effects of new powerful thromboxane antagonists (3-alkylamino pinane derivatives).
    Katsura M; Miyamoto T; Hamanaka N; Kondo K; Terada T; Ohgaki Y; Kawasaki A; Tsuboshima M
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():351-7. PubMed ID: 6221545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.